86,329 XNAS Volume
XNAS 19 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Joseph Anthony Selsavage | Chief Financial & Actng Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.74 per share. | 20 Feb 2025 | 5,654 | 96,468 | - | 2.7 | 15,492 | Class A Common Stock |
| Joseph Anthony Selsavage | Chief Financial & Actng Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.15 per share. | 20 Nov 2024 | 5,279 | 102,122 | - | 3.2 | 16,629 | Class A Common Stock |
| Sandra R. Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.33 per share. | 26 Aug 2024 | 149,655 | 1,203,204 | - | 0.3 | 50,000 | Class A Common Stock |
| Sandra R. Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 658,485 | 1,053,549 | - | 0 | Class A Common Stock | |
| Richard H. Scheller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 658,485 | 895,961 | - | 0 | Class A Common Stock | |
| Peter J. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 658,485 | 981,217 | - | 0 | Class A Common Stock | |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.33 per share. | 26 Aug 2024 | 179,586 | 483,526 | - | 0.3 | 60,000 | Class A Common Stock |
| Roelof Frederik Botha | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 658,485 | 658,485 | - | 0 | Class A Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 658,485 | 1,013,366 | - | 0 | Class A Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.33 per share. | 26 Aug 2024 | 194,552 | 1,207,918 | - | 0.3 | 65,000 | Class A Common Stock |
| Neal Mohan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 658,485 | 904,291 | - | 0 | Class A Common Stock | |
| Patrick Chung | Director | Grant, award, or other acquisition of securities at price $ 0.33 per share. | 26 Aug 2024 | 202,035 | 1,161,941 | - | 0.3 | 67,500 | Class A Common Stock |
| Patrick Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Aug 2024 | 658,485 | 959,906 | - | 0 | Class A Common Stock | |
| Joseph Anthony Selsavage | Chief Financial & Actng Ofcr | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. | 20 Aug 2024 | 110,388 | 2,148,002 | - | 0.4 | 39,243 | Class A Common Stock |
| William G. Richards | Head of Therapeutics Discovery | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.36 per share. | 20 Aug 2024 | 57,365 | 573,069 | - | 0.4 | 20,393 | Class A Common Stock |
| Sandra R. Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 57,515 | 395,064 | - | 0 | Class A Common Stock | |
| Peter J. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 57,515 | 322,732 | - | 0 | Class A Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 15,337 | 354,881 | - | 0 | Class A Common Stock | |
| Joseph Anthony Selsavage | Chief Financial & Actng Ofcr | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2024 | 1,000,000 | 2,258,390 | - | 0 | Class A Common Stock | |
| Kathy L. Hibbs | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.55 per share. | 20 May 2024 | 35,282 | 1,217,033 | - | 0.5 | 19,285 | Class A Common Stock |
| Joseph Anthony Selsavage | Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.55 per share. | 20 May 2024 | 36,913 | 1,258,390 | - | 0.5 | 20,177 | Class A Common Stock |
| William G. Richards | Head of Therapeutics Discovery | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.55 per share. | 20 May 2024 | 16,106 | 630,434 | - | 0.5 | 8,804 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 38,551 | 0 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.49 per share. | 02 May 2024 | 38,551 | 1,252,315 | - | 0.5 | 19,048 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 02 May 2024 | 38,551 | 1,290,866 | - | 0.4 | 16,191 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 18 Apr 2024 | 38,548 | 1,290,863 | - | 0.4 | 16,190 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2024 | 38,548 | 38,551 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.47 per share. | 18 Apr 2024 | 38,548 | 1,252,315 | - | 0.5 | 18,148 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Apr 2024 | 38,548 | 77,099 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.50 per share. | 04 Apr 2024 | 38,548 | 1,252,315 | - | 0.5 | 19,282 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 04 Apr 2024 | 38,548 | 1,290,863 | - | 0.4 | 16,190 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Mar 2024 | 38,548 | 115,647 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.46 per share. | 21 Mar 2024 | 38,548 | 1,252,315 | - | 0.5 | 17,894 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 21 Mar 2024 | 38,548 | 1,290,863 | - | 0.4 | 16,190 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 07 Mar 2024 | 38,548 | 1,290,863 | - | 0.4 | 16,190 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 38,548 | 154,195 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.53 per share. | 07 Mar 2024 | 38,548 | 1,252,315 | - | 0.5 | 20,430 | Class A Common Stock |
| Hibbs Kathy L. | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2024 | 38,548 | 192,743 | - | - | Stock Option (Right to Buy) | |
| L. Kathy Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 22 Feb 2024 | 38,548 | 1,239,827 | - | 0.6 | 23,325 | Class A Common Stock |
| Hibbs Kathy L. | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 22 Feb 2024 | 38,548 | 1,278,375 | - | 0.4 | 16,190 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.72 per share. | 20 Feb 2024 | 40,522 | 1,239,827 | - | 0.7 | 29,014 | Class A Common Stock |
| Selsavage Joseph Anthony | Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.72 per share. | 20 Feb 2024 | 42,395 | 1,273,659 | - | 0.7 | 30,355 | Class A Common Stock |
| Richards G. William | Head of Therapeutics Discovery | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.72 per share. | 20 Feb 2024 | 18,497 | 646,540 | - | 0.7 | 13,244 | Class A Common Stock |
| Hibbs Kathy L. | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 15 Feb 2024 | 38,548 | 1,318,897 | - | 0.4 | 16,190 | Class A Common Stock |
| Kathy Hibbs L. | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 38,548 | 231,291 | - | - | Stock Option (Right to Buy) | |
| L. Kathy Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.78 per share. | 15 Feb 2024 | 38,548 | 1,280,349 | - | 0.8 | 30,210 | Class A Common Stock |
| L. Kathy Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.73 per share. | 25 Jan 2024 | 38,548 | 1,280,349 | - | 0.7 | 27,997 | Class A Common Stock |
| Kathy Hibbs L. | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Jan 2024 | 38,548 | 269,839 | - | - | Stock Option (Right to Buy) | |
| L. Hibbs Kathy | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 25 Jan 2024 | 38,548 | 1,318,897 | - | 0.4 | 16,190 | Class A Common Stock |
| Hibbs Kathy L. | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 11 Jan 2024 | 38,548 | 1,318,897 | - | 0.4 | 16,190 | Class A Common Stock |
| L. Kathy Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2024 | 38,548 | 308,387 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.72 per share. | 11 Jan 2024 | 38,548 | 1,280,349 | - | 0.7 | 27,581 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Dec 2023 | 38,548 | 346,935 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 28 Dec 2023 | 38,548 | 1,318,897 | - | 0.4 | 16,190 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.93 per share. | 28 Dec 2023 | 38,548 | 1,280,349 | - | 0.9 | 35,904 | Class A Common Stock |
| L. Hibbs Kathy | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Dec 2023 | 38,548 | 385,483 | - | - | Stock Option (Right to Buy) | |
| L. Kathy Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 14 Dec 2023 | 38,548 | 1,318,897 | - | 0.4 | 16,190 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 0.97 per share. | 14 Dec 2023 | 38,548 | 1,280,349 | - | 1.0 | 37,222 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Aug 2023 | 40,894 | 755,015 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 1.05 per share. | 24 Aug 2023 | 40,894 | 252,512 | - | 1.1 | 43,119 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 24 Aug 2023 | 40,894 | 293,406 | - | 0.4 | 17,175 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 20 Aug 2023 | 4,628 | 252,512 | - | 1.1 | 5,276 | Class A Common Stock |
| Joseph Anthony Selsavage | Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 20 Aug 2023 | 6,209 | 286,537 | - | 1.1 | 7,078 | Class A Common Stock |
| William G. Richards | Head of Therapeutics Discovery | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.14 per share. | 20 Aug 2023 | 8,185 | 211,041 | - | 1.1 | 9,331 | Class A common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 1.32 per share. | 15 Aug 2023 | 40,894 | 257,140 | - | 1.3 | 53,939 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 40,894 | 795,909 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 15 Aug 2023 | 40,894 | 298,034 | - | 0.4 | 17,175 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 27 Jul 2023 | 40,894 | 298,034 | - | 0.4 | 17,175 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 1.89 per share. | 27 Jul 2023 | 40,894 | 257,140 | - | 1.9 | 77,257 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jul 2023 | 40,894 | 836,803 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2023 | 40,894 | 877,697 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 1.82 per share. | 13 Jul 2023 | 40,894 | 257,140 | - | 1.8 | 74,239 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 13 Jul 2023 | 40,894 | 298,034 | - | 0.4 | 17,175 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 29 Jun 2023 | 40,894 | 298,034 | - | 0.4 | 17,175 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jun 2023 | 40,894 | 918,591 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 1.72 per share. | 29 Jun 2023 | 40,894 | 257,140 | - | 1.7 | 70,432 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.08 per share. | 05 Jun 2023 | 15,098 | 257,140 | - | 2.1 | 31,404 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 43,659 | 272,238 | - | 0 | Class A Common Stock | |
| Kenneth J. Hillan | Chief Therapeutics Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.08 per share. | 05 Jun 2023 | 15,347 | 221,876 | - | 2.1 | 31,922 | Class A Common Stock |
| Kenneth J. Hillan | Chief Therapeutics Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 44,381 | 237,223 | - | 0 | Class A Common Stock | |
| Joseph Anthony Selsavage | Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.08 per share. | 05 Jun 2023 | 13,075 | 292,746 | - | 2.1 | 27,196 | Class A Common Stock |
| Joseph Anthony Selsavage | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2023 | 37,808 | 305,821 | - | 0 | Class A Common Stock | |
| Kathy L. Hibbs | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.94 per share. | 20 May 2023 | 4,628 | 228,579 | - | 1.9 | 8,978 | Class A Common Stock |
| Kenneth J. Hillan | Chief Therapeutics Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.94 per share. | 20 May 2023 | 4,628 | 192,842 | - | 1.9 | 8,978 | Class A Common Stock |
| Joseph Anthony Selsavage | Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.94 per share. | 20 May 2023 | 6,209 | 268,013 | - | 1.9 | 12,045 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.87 per share. | 20 Feb 2023 | 5,457 | 230,372 | - | 2.9 | 15,662 | Class A Common Stock |
| Kenneth J. Hillan | Chief Therapeutics Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.87 per share. | 20 Feb 2023 | 5,457 | 191,705 | - | 2.9 | 15,662 | Class A Common Stock |
| Joseph Anthony Selsavage | Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.87 per share. | 20 Feb 2023 | 7,321 | 269,957 | - | 2.9 | 21,011 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Sale of securities on an exchange or to another person at price $ 3.25 per share. | 05 Dec 2022 | 26,259 | 235,829 | - | 3.3 | 85,342 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 20 Nov 2022 | 4,628 | 262,088 | - | 3.0 | 13,838 | Class A Common Stock |
| Kenneth J. Hillan | Chief Therapeutics Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 20 Nov 2022 | 4,628 | 197,162 | - | 3.0 | 13,838 | Class A Common Stock |
| Joseph Anthony Selsavage | Interim CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 20 Nov 2022 | 10,105 | 277,278 | - | 3.0 | 30,214 | Class A Common Stock |
| Richard H. Scheller | Director | Sale of securities on an exchange or to another person at price $ 3.24 per share. | 11 Nov 2022 | 18,421 | 72,388 | - | 3.2 | 59,684 | Class A Common Stock |
| Sandra R. Hernandez | Director | Grant, award, or other acquisition of securities at price $ 3.08 per share. | 06 Sep 2022 | 3,251 | 143,186 | - | 3.1 | 10,013 | Class A Common Stock |
| Sandra R. Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 14,633 | 139,935 | - | 0 | Class A Common Stock | |
| Richard H. Scheller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 14,633 | 90,809 | - | 0 | Class A Common Stock | |
| Peter J. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 14,633 | 127,651 | - | 0 | Class A Common Stock | |
| Roelof Frederik Botha | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 14,633 | 107,310 | - | 0 | Class A Common Stock | |
| Roelof Frederik Botha | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 3.08 per share. | 06 Sep 2022 | 3,251 | 110,561 | - | 3.1 | 10,013 | Class A Common Stock |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 3.08 per share. | 06 Sep 2022 | 3,577 | 149,049 | - | 3.1 | 11,017 | Class A Common Stock |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 14,633 | 145,472 | - | 0 | Class A Common Stock | |
| Neal Mohan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 14,633 | 90,809 | - | 0 | Class A Common Stock | |
| Patrick Chung | Director | Grant, award, or other acquisition of securities at price $ 3.08 per share. | 06 Sep 2022 | 3,414 | 113,034 | - | 3.1 | 10,515 | Class A Common Stock |
| Patrick Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 14,633 | 109,620 | - | 0 | Class A Common Stock | |
| Joseph Anthony Selsavage | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 190,131 | 190,131 | - | - | Stock Option (Right to Buy) | |
| Joseph Anthony Selsavage | Interim CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Sep 2022 | 129,761 | 287,383 | - | 0 | Class A Common Stock | |
| Sandra R. Hernandez | Director | Grant, award, or other acquisition of securities at price $ 3.03 per share. | 25 Aug 2022 | 13,201 | 125,302 | - | 3.0 | 39,999 | Class A Common Stock |
| Sandra R. Hernandez | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 57,755 | 112,101 | - | 0 | Class A Common Stock | |
| Richard H. Scheller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 57,755 | 76,176 | - | 0 | Class A Common Stock | |
| Peter J. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 57,755 | 113,018 | - | 0 | Class A Common Stock | |
| Roelof Frederik Botha | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 3.03 per share. | 25 Aug 2022 | 16,501 | 92,677 | - | 3.0 | 49,998 | Class A Common Stock |
| Roelof Frederik Botha | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 57,755 | 76,176 | - | 0 | Class A Common Stock | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 3.03 per share. | 25 Aug 2022 | 17,821 | 130,839 | - | 3.0 | 53,998 | Class A Common Stock |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 57,755 | 113,018 | - | 0 | Class A Common Stock | |
| Neal Mohan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 57,755 | 76,176 | - | 0 | Class A Common Stock | |
| Patrick Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Aug 2022 | 57,755 | 76,176 | - | 0 | Class A Common Stock | |
| Patrick Chung | Director | Grant, award, or other acquisition of securities at price $ 3.03 per share. | 25 Aug 2022 | 18,811 | 94,987 | - | 3.0 | 56,997 | Class A Common Stock |
| Kenneth J. Hillan | Chief Therapeutics Officer | Sale of securities on an exchange or to another person at price $ 3.64 per share. | 24 Aug 2022 | 8,753 | 196,083 | - | 3.6 | 31,861 | Class A Common Stock |
| Kathy L. Hibbs | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.33 per share. | 20 Aug 2022 | 4,628 | 263,636 | - | 3.3 | 15,411 | Class A Common Stock |
| Kenneth J. Hillan | Chief Therapeutics Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.33 per share. | 20 Aug 2022 | 4,628 | 204,836 | - | 3.3 | 15,411 | Class A Common Stock |
| Steven J. Schoch | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.33 per share. | 20 Aug 2022 | 4,782 | 211,663 | - | 3.3 | 15,924 | Class A Common Stock |
| Evan M. Lovell | Director | Other type of transaction at price $ 0.00 per share. | 11 Aug 2022 | 1,217,077 | 1,228,544 | - | 0 | Class A Common Stock | |
| Evan M. Lovell | Director | Other type of transaction at price $ 0.00 per share. | 11 Aug 2022 | 35 | 15 | - | - | Class C Shares in VG Acquisition Sponsor LLC | |
| Kathy L. Hibbs | Chief Administrative Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.82 per share. | 01 Jun 2022 | 4,627 | 268,264 | - | 2.8 | 13,048 | Class A Common Stock |
| Kenneth J. Hillan | Chief Therapeutics Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.82 per share. | 01 Jun 2022 | 4,627 | 209,464 | - | 2.8 | 13,048 | Class A Common Stock |
| Steven J. Schoch | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.82 per share. | 01 Jun 2022 | 4,782 | 216,445 | - | 2.8 | 13,485 | Class A Common Stock |
| Anne Wojcicki | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2022 | 7,500,000 | 7,500,000 | - | - | Stock Option (Right to Buy) | |
| Evan M. Lovell | Director | Purchase of securities on an exchange or from another person at price $ 4.41 per share. | 10 Mar 2022 | 11,467 | 11,467 | - | 4.4 | 50,558 | Class A Common Stock |
| Tracy Keim | VP, Consumer Marketing & Brand | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 274,991 | 274,991 | - | - | Stock Option (Right to Buy) | |
| Tracy Keim | VP, Consumer Marketing & Brand | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 124,886 | 124,886 | - | 0 | Class A Common Stock | |
| Fred Kohler | Vice President, People | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 71,364 | 71,364 | - | 0 | Class A Common Stock | |
| Fred Kohler | Vice President, People | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 157,138 | 157,138 | - | - | Stock Option (Right to Buy) | |
| Steve Lemon | Vice President, Engineering | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 314,276 | 314,276 | - | - | Stock Option (Right to Buy) | |
| Steve Lemon | Vice President, Engineering | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2022 | 142,727 | 270,374 | - | 0 | Class A Common Stock | |
| Kathy L. Hibbs | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2022 | 58,800 | 900,685 | - | - | Stock Option (Right to Buy) | |
| Kathy L. Hibbs | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.42 per share. | 06 Jan 2022 | 58,800 | 58,800 | - | 0.4 | 24,696 | Class A Common Stock, $0.0001 par value |
| Steve Lemon | Vice President, Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Jan 2022 | 127,647 | 0 | - | - | Stock Option (Right to Buy) | |
| Steve Lemon | Vice President, Engineering | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.23 per share. | 05 Jan 2022 | 127,647 | 127,647 | - | 0.2 | 29,359 | Class A Common Stock, $0.0001 par value |
| Paul D. Johnson | VP, General Manager-Consumer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 414,886 | 414,886 | - | - | Stock Option (Right to Buy) | |
| Richard H. Scheller | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 18,421 | 18,421 | - | 0 | Class A Common Stock, $0.0001 par value | |
| Peter J. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 18,421 | 55,263 | - | 0 | Class A Common Stock, $0.0001 par value | |
| Peter J. Taylor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 36,842 | 36,842 | - | 0 | Class A Common Stock, $0.0001 par value | |
| Roelof Frederik Botha | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 18,421 | 18,421 | - | 0 | Class A Common Stock, $0.0001 par value | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 36,842 | 36,842 | - | 0 | Class A Common Stock, $0.0001 par value | |
| Valerie Montgomery Rice | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 18,421 | 55,263 | - | 0 | Class A Common Stock, $0.0001 par value | |
| Neal Mohan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 18,421 | 18,421 | - | 0 | Class A Common Stock, $0.0001 par value | |
| Patrick Chung | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Sep 2021 | 18,421 | 18,421 | - | 0 | Class A Common Stock, $0.0001 par value |